Filed: 2/14/2024ACC: 0001931118-24-000005
📋 What this filing means
SUPERSTRING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $140.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$140.10M
Total AUM (reported)
8.90M
Total Shares
Allocation by class
COM$112.12M80.0%
COM NEW$19.85M14.2%
SHS$4.50M3.2%
SPONSORED ADS$3.47M2.5%
ORDINARY SHARES$165.7K0.1%
Portfolio Concentration
Top 3$43.97M31.4%
4–10$54.70M39.0%
11–25$39.23M28.0%
Rest$2.19M1.6%
Top 3 weight
31.4%
Top 10 weight
70.4%
Voting Authority Distribution
Total shares with voting rights: 8.90M
Sole
Full voting authority
8.90M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
IMMUNOGEN INC
SOLEShares598.07K
TypeSH
Market value$17.73M
12.66%
Sole
598.07K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares177.60K
TypeSH
Market value$14.83M
10.58%
Sole
177.60K
Shared
0.00
None
0.00
89BIO INC
SOLEShares1.02M
TypeSH
Market value$11.41M
8.14%
Sole
1.02M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares189.62K
TypeSH
Market value$9.59M
6.85%
Sole
189.62K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares251.29K
TypeSH
Market value$8.94M
6.38%
Sole
251.29K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares379.14K
TypeSH
Market value$8.69M
6.21%
Sole
379.14K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares203.59K
TypeSH
Market value$8.58M
6.12%
Sole
203.59K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares206.33K
TypeSH
Market value$8.33M
5.95%
Sole
206.33K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares379.63K
TypeSH
Market value$5.54M
3.96%
Sole
379.63K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares462.44K
TypeSH
Market value$5.03M
3.59%
Sole
462.44K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares29.35K
TypeSH
Market value$3.87M
2.76%
Sole
29.35K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares255.43K
TypeSH
Market value$3.83M
2.73%
Sole
255.43K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares814.27K
TypeSH
Market value$3.83M
2.73%
Sole
814.27K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares326.16K
TypeSH
Market value$3.66M
2.61%
Sole
326.16K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares54.90K
TypeSH
Market value$3.40M
2.43%
Sole
54.90K
Shared
0.00
None
0.00
FATE THERAPEUTICS INC
SOLEShares847.82K
TypeSH
Market value$3.17M
2.26%
Sole
847.82K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares74.65K
TypeSH
Market value$2.97M
2.12%
Sole
74.65K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares356.92K
TypeSH
Market value$2.66M
1.90%
Sole
356.92K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares124.04K
TypeSH
Market value$2.47M
1.76%
Sole
124.04K
Shared
0.00
None
0.00
NKARTA INC
SOLEShares347.38K
TypeSH
Market value$2.29M
1.64%
Sole
347.38K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares16.09K
TypeSH
Market value$2.00M
1.42%
Sole
16.09K
Shared
0.00
None
0.00
QUANTERIX CORP
SOLEShares71.76K
TypeSH
Market value$1.96M
1.40%
Sole
71.76K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares16.18K
TypeSH
Market value$1.29M
0.92%
Sole
16.18K
Shared
0.00
None
0.00
SO YOUNG INTERNATIONAL INC
SOLEShares796.06K
TypeSH
Market value$1.00M
0.72%
Sole
796.06K
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares79.21K
TypeSH
Market value$834.1K
0.60%
Sole
79.21K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IMMUNOGEN INCSOLE | COM | 598.07K | SH | $17.73M 12.66% | 598.07K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 177.60K | SH | $14.83M 10.58% | 177.60K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 1.02M | SH | $11.41M 8.14% | 1.02M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 189.62K | SH | $9.59M 6.85% | 189.62K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 251.29K | SH | $8.94M 6.38% | 251.29K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 379.14K | SH | $8.69M 6.21% | 379.14K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 203.59K | SH | $8.58M 6.12% | 203.59K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 206.33K | SH | $8.33M 5.95% | 206.33K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 379.63K | SH | $5.54M 3.96% | 379.63K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 462.44K | SH | $5.03M 3.59% | 462.44K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 29.35K | SH | $3.87M 2.76% | 29.35K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 255.43K | SH | $3.83M 2.73% | 255.43K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 814.27K | SH | $3.83M 2.73% | 814.27K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 326.16K | SH | $3.66M 2.61% | 326.16K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 54.90K | SH | $3.40M 2.43% | 54.90K | 0.00 | 0.00 |
FATE THERAPEUTICS INCSOLE | COM | 847.82K | SH | $3.17M 2.26% | 847.82K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 74.65K | SH | $2.97M 2.12% | 74.65K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 356.92K | SH | $2.66M 1.90% | 356.92K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 124.04K | SH | $2.47M 1.76% | 124.04K | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 347.38K | SH | $2.29M 1.64% | 347.38K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 16.09K | SH | $2.00M 1.42% | 16.09K | 0.00 | 0.00 |
QUANTERIX CORPSOLE | COM | 71.76K | SH | $1.96M 1.40% | 71.76K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 16.18K | SH | $1.29M 0.92% | 16.18K | 0.00 | 0.00 |
SO YOUNG INTERNATIONAL INCSOLE | SPONSORED ADS | 796.06K | SH | $1.00M 0.72% | 796.06K | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 79.21K | SH | $834.1K 0.60% | 79.21K | 0.00 | 0.00 |
Page 1 of 2